Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Meca-Lallana, JE
- Prefasi, D
- Forero, L
- Sepulveda, M
- Calles, C
- Martinez-Gines, ML
- Gonzalez-Suarez, I
- Boyero, S
- Romero-Pinel, L
- Sempere, AP
- Meca-Lallana, V
- Querol, L
- Costa-Frossard, L
- De Castro-Trapiello, H
- Canal, N
- Maurino, J
Grupos
Abstract
Background: Perception of stigma was associated with low self-esteem, psychological problems, and decreased health-seeking behavior among patients with different neurological disorders. The purpose of this study was to assess stigmatization and its impact in patients with neuromyelitis optica spectrum disorder (NMOSD). Methods: A non-interventional study was conducted at thirteen neuroimmunology clinics in Spain. Patients with a diagnosis of NMOSD (2015 Wingerchuk criteria) were included. The 8-item Stigma Scale for Chronic Illness (SSCI-8), the Expanded Disability Status Scale (EDSS), the 29-item Multiple Sclerosis Impact Scale (MSIS-29), the Beck Depression Inventory-Fast Screen (BDI-FS), the MOS Pain Effects Scale (MOS-PES) and the Fatigue Impact Scale for Daily Use (D-FIS) were used to assess the perception of stigma, disability, quality of life, mood, pain, and fatigue, respectively. Associations between outcome measures were analyzed using Spearman's rank correlation. Results: Seventy-one patients were studied (mean age: 47.4 years +/- 14.9, 81.7% female, mean time since disease onset: 9.9 years +/- 8.1). The median EDSS score was 3.0 (inter-quartile range 1.5, 4.5). Stigma prevalence was 61.4% (n=43). Thirty-one patients (43.6%) had depression. The SSCI-8 score showed a significant correlation with both physical (rho=0.576, p<0.0001) and psychological (rho=0.608, p<0.0001) MSIS-29 scales scores, EDSS score (rho=0.349, p=0.0033), BDI-FS score (rho = 0.613, p<0.0001), MOS-PES score (rho= 0.457, p<0.0001), and D-FIS score (rho=0.556, p<0.0001). Conclusion: Stigma is a common phenomenon affecting over 6 out of 10 patients with NMOSD. Understanding stigma may be useful to develop educational strategies improving NMOSD knowledge.
Datos de la publicación
- ISSN/ISSNe:
- 1177-889X, 1177-889X
- Tipo:
- Article
- Páginas:
- 713-719
- DOI:
- 10.2147/PPA.S305707
- PubMed:
- 33880015
- Factor de Impacto:
- 0,629 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Patient Preference and Adherence DOVE MEDICAL PRESS LTD
Citas Recibidas en Web of Science: 13
Documentos
- No hay documentos
Filiaciones
Keywords
- neuromyelitis optica spectrum disorder; stigma; quality of life; depression; patient-reported outcomes
Campos de Estudio
Cita
Meca JE,Prefasi D,PEREZ F,Forero L,Sepulveda M,Calles C,Martinez ML,Gonzalez I,Boyero S,Romero L,Sempere AP,Meca V,Querol L,Costa L,De Castro H,Canal N,Maurino J. Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder. Patient Prefer. Adherence. 2021. 15. p. 713-719. IF:2,314. (3).
Portal de investigación